Area of research
Oncology · Immunology
Research interest
Research interests include CAR-T cell therapy research, Immunotherapy and Immune Responses, Cutaneous Melanoma Detection and Management, and Cancer Immunotherapy and Biomarkers.
Obesity drives depot-specific vascular remodeling in male white adipose tissue
HAPLN1 potentiates peritoneal metastasis in pancreatic cancer
Endothelial Notch1 signaling in white adipose tissue promotes cancer cachexia
Semaphorin 3C exacerbates liver fibrosis
Ketone body oxidation increases cardiac endothelial cell proliferation
Endothelial RBPJ Is Essential for the Education of Tumor-Associated Macrophages
HAPLN1 is a driver for peritoneal carcinomatosis in pancreatic cancer
Semaphorin 3C exacerbates liver fibrosis
Endothelial Rbpj is essential for the education of tumour-associated macrophages
Endothelial Notch signaling controls insulin transport in muscle
Intraperitoneal Oil Application Causes Local Inflammation with Depletion of Resident Peritoneal Macrophages
Intraperitoneal oil application causes local inflammation with depletion of resident peritoneal macrophages
Loss of the serine protease HTRA1 impairs smooth muscle cells maturation
MPDZ promotes DLL4-induced Notch signaling during angiogenesis
Inactivation of the serine protease HTRA1 inhibits tumor growth by deregulating angiogenesis
STAT5 expression correlates with recurrence and survival in melanoma patients treated with interferon-α
Author response: MPDZ promotes DLL4-induced Notch signaling during angiogenesis
Endothelial Notch1 Activity Facilitates Metastasis
Loss of Mpdz impairs ependymal cell integrity leading to perinatal‐onset hydrocephalus in mice
Soluble Notch ligand and receptor peptides act antagonistically during angiogenesis
ANKS1B Interacts with the Cerebral Cavernous Malformation Protein-1 and Controls Endothelial Permeability but Not Sprouting Angiogenesis
Genetic Evolution of T-cell Resistance in the Course of Melanoma Progression
<i>TERT</i> Promoter Mutations in Familial and Sporadic Melanoma
Genetic and clinico-pathologic analysis of metastatic uveal melanoma
Influence of Genetic Variants in Type I Interferon Genes on Melanoma Survival and Therapy